Median Technologies (XPAR:ALMDT) Total Liabilities : €46.23 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Median Technologies Total Liabilities?

Median Technologies's Total Liabilities for the quarter that ended in Dec. 2023 was €46.23 Mil.

Median Technologies's quarterly Total Liabilities declined from Dec. 2022 (€42.01 Mil) to Jun. 2023 (€38.40 Mil) but then increased from Jun. 2023 (€38.40 Mil) to Dec. 2023 (€46.23 Mil).

Median Technologies's annual Total Liabilities declined from Dec. 2021 (€44.45 Mil) to Dec. 2022 (€42.01 Mil) but then increased from Dec. 2022 (€42.01 Mil) to Dec. 2023 (€46.23 Mil).

Median Technologies Total Liabilities Historical Data

The historical data trend for Median Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Technologies Total Liabilities Chart

Median Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

14.84

36.65

44.45

42.01

46.23

Median Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															44.45	43.39	42.01	38.40	46.23

Median Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Median Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	22.721	+	(19.223	+	3.304
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.981)
	=	46.23

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	35.935	-	-10.294
	=	46.23

Median Technologies's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	22.721	+	(19.223	+	3.304
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.981)
	=	46.23

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	35.935	-	-10.294
	=	46.23

Median Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Median Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Technologies (XPAR:ALMDT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

4ZG:Germany

Address

1800 Route Des Cretes, Les Deux Arcs B, Valbonne, FRA, 06560

Website

https://www.mediantechnologies.com

Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.

Median Technologies (XPAR:ALMDT) Headlines

No Headlines